Skip to content
hcg-service-hero-1

Insights From Halloran

Halloran Consulting GroupJan 8, 2025 7:00:00 AM< 1 min read

Groundbreaking Rare Disease Drug Approval (OGSIVEO [nirogacestat]) Propelled by Expert Regulatory Strategy and Program Management

Rare Disease Drug Approval (OGSIVEO [nirogacestat]) To translate the regulatory strategy ...
Start Reading
Rich DanielsJan 6, 2025 9:45:00 AM6 min read

Bridging Continents for Clinical Development

An Interview with Experts on the Australia and United States Global Partnership Advantage
Start Reading
Rich DanielsDec 31, 2024 9:31:00 AM4 min read

Successfully Managing the Transition from Research to Development

The journey from research to development is one of the most critical phases in drug ...
Start Reading
Halloran Consulting GroupDec 17, 2024 7:12:38 PM4 min read

The Butterfly Effect in Clinical Trials: Enhancing Study Quality Through Effective Training

What is The Butterfly Effect?
Start Reading
Eric MossDec 16, 2024 12:52:49 PM2 min read

Three Ways to Accelerate from Trial to Market

Start Reading
Halloran Consulting GroupDec 9, 2024 11:54:24 AM< 1 min read

Best Of Series: Clinical Trial Conduct

ON-DEMAND WEBINAR
Start Reading
Halloran Consulting GroupDec 6, 2024 6:00:00 AM< 1 min read

Turning Your Inspection Fears into Actionable Readiness Steps

As a clinical leader, being inspection ready is critical in the success of an FDA drug or ...
Start Reading
Elizabeth BodiDec 4, 2024 1:00:00 PM< 1 min read

On-Demand: Inspection Readiness A Failure to Plan is a Plan to Fail

ON-DEMAND WEBINAR
Start Reading
Michelle PeterNov 29, 2024 11:16:51 AM< 1 min read

Best Content 2024: Managing a Trial Master File

2024 Best of Content
Start Reading
Sheila GwizdakNov 25, 2024 10:30:00 AM2 min read

Disrupting the Clinical Trial Ecosystem

Start Reading